Surgery Partners, Inc.

NASDAQ:SGRY

32.16 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 762.1717.4735.4674.1667.6666.2707.1620.6615.4596.2610.2559.2543.3512.4548.3496.1374.7441517.2452445.4416.8491.168443.932444.775417.369460.346282.682288.353286.183306.001282.682289.681267.074263.322239.599232.827224.143179.69176.30375.10869.158
Cost of Revenue 617.7595.8572.9508.3513.5532.2522.8489.4480.8471.4463.1436.7425408.9412.9381.9319.3366.2388353.1340.4326.1359.74334.289340.09327.312338.704201.394216.452211.948214.247201.394208.852196.703183.174168.821161.558155.773120.58745.37745.16143.053
Gross Profit 144.4121.6162.5165.8154.1134184.3131.2134.6124.8147.1122.5118.3103.5135.4114.255.474.8129.298.910590.7131.428109.643104.68590.057121.64281.28871.90174.23591.75481.28880.82970.37180.14870.77871.26968.3759.10430.92629.94726.105
Gross Profit Ratio 0.1890.170.2210.2460.2310.2010.2610.2110.2190.2090.2410.2190.2180.2020.2470.230.1480.170.250.2190.2360.2180.2680.2470.2350.2160.2640.2880.2490.2590.30.2880.2790.2630.3040.2950.3060.3050.3290.4050.3990.377
Reseach & Development Expenses 000000000000000000000000000000000000000000
General & Administrative Expenses 40.333.220.9109.231.23228.717.926.129.527.225.524.526.823.825.225.322.823.719.923.321.723.82919.47826.09924.15221.37635.84118.65515.54118.04114.98515.02312.19721.04811.23611.84611.86211.4146.7386.4656.835
Selling & Marketing Expenses 0-82.60000000000000000000000000272.15900000000000000
SG&A 40.333.220.9109.231.23228.717.926.129.527.225.524.526.823.825.225.322.823.719.923.321.723.82919.47826.09924.15221.37630818.65515.54118.04114.98515.02312.19721.04811.23611.84611.86211.4146.7386.4656.835
Other Expenses 6.50-32.601.232.62929.325.326.212.20.517.510.614.234-19.901,352.100-2.41,454.59910.260025.3292.59900807.525-3.73304.24-119.9110000000
Operating Expenses 40.333.220.9109.254.464.657.747.251.455.73250.24237.436.359.25.443.142.938.34240.541.72346.77148.84845.67648.65330835.69932.18136.1733.57628.30725.60235.54725.41425.37125.49719.65410.9559.43611.738
Operating Income 104.188.4141.682.697.672.4140.274.176.574.6114.863.659.564.396.318.544.723.571.85955.549.6-51.88945.00343.56141.16380.34442.84837.73941.72168.40742.84850.94834.2821.12844.27441.00138.351-3.66719.65420.6216.41
Operating Income Ratio 0.1370.1230.1930.1230.1460.1090.1980.1190.1240.1250.1880.1140.110.1250.1760.0370.1190.0530.1390.1310.1250.119-0.1060.1010.0980.0990.1750.1520.1310.1460.2240.1520.1760.1280.080.1850.1760.171-0.020.2580.2750.237
Total Other Income Expenses Net -70.8-59.7-88.9-49.8-2.1-72.8-107-60.7-56.9-30.5-0.3-8.7-16.8-1.8-2.8-36.5-5.3-8.2-14.5-1.6-7.5-3-141.594-17.869-12.276-3.21832.684-30.2081.537-0.33312.823-8.597-1.574-10.489-143.384-1.09-4.897-4.522-43.117-0.317-11.517-12.149
Income Before Tax 33.328.752.732.849.9-0.433.213.419.644.154.79.46.11142.3-33-4.5-23.62713.39.15.2-91.5247.8447.6286.88772.81612.6412.13916.53942.69912.6424.71312.127-121.25617.70114.82312.595-33.058.3919.1034.261
Income Before Tax Ratio 0.0440.040.0720.0490.075-0.0010.0470.0220.0320.0740.090.0170.0110.0210.077-0.067-0.012-0.0540.0520.0290.020.012-0.1860.0180.0170.0170.1580.0450.0420.0580.140.0450.0850.045-0.460.0740.0640.056-0.1840.110.1210.062
Income Tax Expense 4.94.46-3.1-7.8-1.69.97.84.31.311.81.2-2.70.2-5.61.3-0.6-15.23.42.411.715.5565.8253.3181.76271.85-1.6940.5122.1174.599-1.6942.421.77-157.353.9172.3442.1073.7157.9612.1181.963
Net Income -15.5-12.4-135.918.91.223.35.615.342.8-0.1-22.9-26.9-215.5-61.6-32.5-27.5-18.2-15.7-19.8-20.1-147.742-20.981-19.462-17.521-32.17614.334-4.471-2.75416.862-2.3382.12-7.1916.739-3.122-5.426-6.762-54.264-6.908-0.647-4.079
Net Income Ratio -0.02-0.017-0.0010.0530.0280.0020.0330.0090.0250.072-0-0.041-0.05-0.0410.01-0.124-0.087-0.062-0.035-0.035-0.044-0.048-0.301-0.047-0.044-0.042-0.070.051-0.016-0.010.055-0.0080.007-0.0270.064-0.013-0.023-0.03-0.302-0.091-0.009-0.059
EPS -0.12-0.098-0.0080.290.150.010.230.0630.170.49-0.001-0.28-0.39-0.38-0.1-1.26-0.67-0.57-0.38-0.32-0.41-0.42-3.07-0.44-0.41-0.37-0.670.3-0.093-0.060.35-0.050.04-0.150.35-0.065-0.11-0.14-1.13-0.1400
EPS Diluted -0.12-0.098-0.0080.290.150.010.230.0630.170.47-0.001-0.28-0.39-0.38-0.1-1.26-0.67-0.57-0.38-0.32-0.41-0.42-3.07-0.44-0.41-0.36-0.670.29-0.093-0.0570.35-0.0490.04-0.150.35-0.065-0.11-0.14-1.13-0.1400
EBITDA 138.9122.1172.711.9126.7106.1169.8118.6113.8102152.8100.4104.594.4127.882.275.955.5110.181.484.368.6110.38181.67875.20961.992119.399-4.12248.67154.36267.90854.85963.30755.095-65.39255.29555.20352.04247.21822.80623.48219.27
EBITDA Ratio 0.1820.170.2350.0180.190.1590.240.1910.1850.1710.250.180.1920.1840.2330.1660.2030.1260.2130.180.1890.1650.2250.1840.1690.1490.259-0.0150.1690.190.2220.1940.2190.206-0.2480.2310.2370.2320.2630.2990.3130.279